November 13, 2021
1 min watch
Save
VIDEO: EyePoint shares phase 1 positive data for wet AMD treatment
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Nosocomial Infections.
Added to email alerts
You've successfully added Nosocomial Infections to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Nosocomial Infections to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW ORLEANS —Nancy Lurker, CEO and board director at EyePoint Pharmaceuticals, discusses topline results of the phase 1 DAVIO study of EYP-1901 for the treatment of wet age-related macular degeneration at the Eyecelerator meeting.
Published by:
Sources/Disclosures
Collapse
Source:
Nancy Lurker
Read more from American Academy of Ophthalmology Meeting
View allJanuary 16, 2025
12 min watch
Save
January 14, 2025
2 min watch
Save
January 14, 2025
1 min watch
Save
January 10, 2025
2 min watch
Save
December 31, 2024
3 min watch
Save
December 31, 2024
6 min watch
Save
December 30, 2024
3 min watch
Save
December 29, 2024
1 min watch
Save
December 27, 2024
3 min watch
Save
Read more about
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Nosocomial Infections.
Added to email alerts
You've successfully added Nosocomial Infections to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Nosocomial Infections to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.